These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 31264276)
1. Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells. Rencuzogulları O; Yerlikaya PO; Gürkan AÇ; Arısan ED; Telci D J Cell Biochem; 2020 Jan; 121(1):508-523. PubMed ID: 31264276 [TBL] [Abstract][Full Text] [Related]
2. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells. Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225 [TBL] [Abstract][Full Text] [Related]
3. Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. Liu F; Korc M Mol Cancer Ther; 2012 Oct; 11(10):2138-48. PubMed ID: 22869556 [TBL] [Abstract][Full Text] [Related]
4. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK-3β/β-catenin signaling. Hao Q; Gao L; Niu W; Chen L; Zhang P; Chen Z Biofactors; 2020 Jul; 46(4):685-692. PubMed ID: 32589786 [TBL] [Abstract][Full Text] [Related]
5. Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. Bonelli MA; Digiacomo G; Fumarola C; Alfieri R; Quaini F; Falco A; Madeddu D; La Monica S; Cretella D; Ravelli A; Ulivi P; Tebaldi M; Calistri D; Delmonte A; Ampollini L; Carbognani P; Tiseo M; Cavazzoni A; Petronini PG Neoplasia; 2017 Aug; 19(8):637-648. PubMed ID: 28704762 [TBL] [Abstract][Full Text] [Related]
6. Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells. Wang F; Wang Q; Zhou ZW; Yu SN; Pan ST; He ZX; Zhang X; Wang D; Yang YX; Yang T; Sun T; Li M; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():537-60. PubMed ID: 25632222 [TBL] [Abstract][Full Text] [Related]
7. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation. Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117 [TBL] [Abstract][Full Text] [Related]
8. Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells. Kishino E; Ogata R; Saitoh W; Koike Y; Ohta Y; Kanomata N; Kurebayashi J Breast Cancer; 2020 May; 27(3):415-425. PubMed ID: 31823286 [TBL] [Abstract][Full Text] [Related]
9. Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI Yang HL; Tsai YC; Korivi M; Chang CT; Hseu YC Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):151-168. PubMed ID: 27816443 [TBL] [Abstract][Full Text] [Related]
10. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells. Lee YJ; Han HJ Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942 [TBL] [Abstract][Full Text] [Related]
11. Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells. Bonelli M; Terenziani R; Zoppi S; Fumarola C; La Monica S; Cretella D; Alfieri R; Cavazzoni A; Digiacomo G; Galetti M; Petronini PG Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708306 [No Abstract] [Full Text] [Related]
12. Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients. Vlenterie M; Hillebrandt-Roeffen MH; Schaars EW; Flucke UE; Fleuren ED; Navis AC; Leenders WP; Versleijen-Jonkers YM; van der Graaf WT Ann Surg Oncol; 2016 Sep; 23(9):2745-52. PubMed ID: 27334220 [TBL] [Abstract][Full Text] [Related]
13. The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia. Zhang J; Zhou L; Zhao S; Dicker DT; El-Deiry WS Cell Cycle; 2017 Jun; 16(12):1193-1200. PubMed ID: 28486050 [TBL] [Abstract][Full Text] [Related]
15. Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature. Knudsen ES; Hutcheson J; Vail P; Witkiewicz AK Oncotarget; 2017 Jul; 8(27):43678-43691. PubMed ID: 28620137 [TBL] [Abstract][Full Text] [Related]
16. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway. Xu Q; Ma J; Lei J; Duan W; Sheng L; Chen X; Hu A; Wang Z; Wu Z; Wu E; Ma Q; Li X Biomed Res Int; 2014; 2014():546353. PubMed ID: 24812621 [TBL] [Abstract][Full Text] [Related]
17. All-trans-retinoid acid induces the differentiation of P19 cells into neurons involved in the PI3K/Akt/GSK3β signaling pathway. Fu F; Li LS; Li R; Deng Q; Yu QX; Yang X; Pan M; Han J; Zhen L; Zhang LN; Lei TY; Li DZ; Liao C J Cell Biochem; 2020 Nov; 121(11):4386-4396. PubMed ID: 31961017 [TBL] [Abstract][Full Text] [Related]
18. HOXB5 promotes proliferation, migration, and invasion of pancreatic cancer cell through the activation of the GSK3β/β-catenin pathway. Gao Y; Fei X; Kong L; Tan X Anticancer Drugs; 2020 Sep; 31(8):828-835. PubMed ID: 32796404 [TBL] [Abstract][Full Text] [Related]
19. Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma. Li N; Jiang S; Fu R; Lv J; Yao J; Mai J; Hua X; Chen H; Liu J; Lu M Biomark Med; 2021 Apr; 15(5):347-358. PubMed ID: 33666519 [No Abstract] [Full Text] [Related]
20. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]